Extracorporeal photopheresis in acute and chronic graft-versus-host disease (Q38208102)

31 August 2017

title

Extracorporeal photopheresis in acute and chronic graft-versus-host disease (English)

1 reference

31 August 2017

Hildegard T Greinix

1 reference

31 August 2017

Nina Worel

series ordinal

1 reference

31 August 2017

Ulrike Just

series ordinal

1 reference

31 August 2017

Robert Knobler

series ordinal

1 reference

31 August 2017

publication date

13 April 2014

1 reference

Transfusion and Apheresis Science

31 August 2017

published in

1 reference

31 August 2017

1 reference

31 August 2017

1 reference

31 August 2017

page(s)

349-357

1 reference

Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Significantly worse survival of patients with NIH-defined chronic graft-versus-host disease and thrombocytopenia or progressive onset type: results of a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Prophylaxis regimens for GVHD: systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Novel drugs for the prevention and treatment of acute GVHD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Assessing the potential role of photopheresis in hematopoietic stem cell transplant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Extracorporeal photopheresis: past, present, and future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Graft-versus-host disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Current practice in diagnosis and treatment of acute graft-versus-host disease: results from a survey among German-Austrian-Swiss hematopoietic stem cell transplant centers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Extracorporeal photochemotherapy for treatment of acute and chronic GVHD in childhood.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Extracorporeal photochemotherapy for paediatric patients with graft-versus-host disease after haematopoietic stem cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Role of extracorporeal photopheresis (ECP) in treatment of steroid-refractory acute graft-versus-host disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Photopheresis in pediatric graft-versus-host disease after allogeneic marrow transplantation: clinical practice guidelines based on field experience and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Extracorporeal photochemotherapy may improve outcome in children with acute GVHD

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Extracorporeal photochemotherapy for steroid-refractory graft-versus-host disease in low-weight pediatric patients. Immunomodulatory effects and clinical outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Extracorporeal photochemotherapy in graft-versus-host disease: a longitudinal study on factors influencing the response and survival in pediatric patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Extracorporeal photopheresis versus anticytokine therapy as a second-line treatment for steroid-refractory acute GVHD: a multicenter comparative analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Diagnosis and management of acute graft-versus-host disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Extracorporeal photopheresis for the treatment of acute and chronic graft-versus-host disease in adults and children: best practice recommendations from an Italian Society of Hemapheresis and Cell Manipulation (SIdEM) and Italian Group for Bone Marr

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Significant differences in B-cell subpopulations characterize patients with chronic graft-versus-host disease–associated dysgammaglobulinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Treatment of chronic graft-versus-host disease: Past, present and future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Extracorporeal photopheresis (ECP) in the treatment of chronic graft-versus-host disease (GVHD)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft-versus-host disease and analysis of predictors of response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Role of extracorporeal photochemotherapy in patients with refractory chronic graft-versus-host disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Treatment of extensive chronic graft-versus-host disease with extracorporeal photochemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Extracorporeal photochemotherapy for the treatment of chronic graft-versus-host disease: trend for a possible cell dose-related effect?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Classic and overlap chronic graft-versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Progressive Improvement in Cutaneous and Extracutaneous Chronic Graft-versus-Host Disease after a 24-Week Course of Extracorporeal Photopheresis—Results of a Crossover Randomized Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Response and survival of patients with chronic graft-versus-host disease treated by extracorporeal photochemotherapy: a retrospective study according to classical and National Institutes of Health classifications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Extracorporeal photopheresis in 62 patients with acute and chronic GVHD: results of treatment with the COBE Spectra System

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Extracorporeal photopheresis in patients with refractory bronchiolitis obliterans developing after allo-SCT.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Extracorporeal photochemotherapy does not suppress T- or B-cell responses to novel or recall antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Update on extracorporeal photochemotherapy for graft-versus-host disease treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Proportions of immature CD19+CD21- B lymphocytes predict the response to extracorporeal photopheresis in patients with chronic graft-versus-host disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

BAFF, APRIL and human B cell disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

CD19(+)CD21(low) B cells and patients at risk for NIH-defined chronic graft-versus-host disease with bronchiolitis obliterans syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Circulating B-cell activating factor level predicts clinical response of chronic graft-versus-host disease to extracorporeal photopheresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Intravenous infusion of syngeneic apoptotic cells by photopheresis induces antigen-specific regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Regulatory T cells and extracorporeal photochemotherapy: correlation with clinical response and decreased frequency of proinflammatory T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Diagnosis and management of chronic graft-versus-host disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

Extracorporeal photochemotherapy for the treatment of graft-versus-host disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2014.04.005

10.1016/J.TRANSCI.2014.04.005

7 January 2021

Identifiers

DOI

1 reference

31 August 2017

1 reference